Correvio Pharma Corp. Soared
Fri, Feb 28, 2020 at 05:30 PM
Correvio Pharma Corp. (CORV:NASDAQ) soared at $0.46, representing a gain of 50.8%. The stock appeared on our News Catalysts scanner on Mon 10 Feb 20 at 03:38 PM in the 'INVESTOR UPDATE' category. From Thu 06 Feb 20, the stock recorded 14.29% Up Days and 20.00% Green Days
The stock spiked on Tue 25 Feb 20 at $0.65 with a volume of 52M+.
About Correvio Pharma Corp. (CORV:NASDAQ)
Cardiome Pharma Corp is a specialty pharmaceutical company. It is engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.
Top 10 Gainers:
- iBio, Inc. (IBIO:NYSEMKT), 183.24%
- Biocept, Inc. (BIOC:NASDAQ), 168.87%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 143.21%
- Altimmune, Inc. (ALT:NASDAQ), 110.23%
- OpGen, Inc. (OPGN:NASDAQ), 66.18%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 62.9%
- Dynatronics Corporation (DYNT:NASDAQ), 59.34%
- Heat Biologics, Inc. (HTBX:NASDAQ), 54.93%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 54.64%
- Correvio Pharma Corp. (CORV:NASDAQ), 50.82%